Investor Relations

Zosano Pharma is an emerging CNS company focusing on providing rapid symptom relief to patients, using known therapeutics with well-established safety and efficacy, but altering their delivery profile using the Company’s proprietary transdermal delivery system. The Company’s goal is to make transdermal drug delivery a standard of care for delivering drugs requiring fast onset of action.

NASDAQ: ZSAN
1.28
- 0.02 (-1.54%)
Day High: 1.32
Day Low:  1.25
Volume:    202,806
4:00 PM ET on Jul 27, 2017

Delayed at least 20 minutes.

Events & Presentations

Upcoming events are not available at this time. Sign up for email alerts.